Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries
出版年份 2014 全文链接
标题
Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries
作者
关键词
-
出版物
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
Volume 48, Issue 6, Pages 512-529
出版商
SAGE Publications
发表日期
2014-05-07
DOI
10.1177/0004867414533012
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The nature of relapse in schizophrenia
- (2013) Robin Emsley et al. BMC Psychiatry
- Imaging Patients with Psychosis and a Mouse Model Establishes a Spreading Pattern of Hippocampal Dysfunction and Implicates Glutamate as a Driver
- (2013) Scott A. Schobel et al. NEURON
- Anatomical Abnormalities in Gray and White Matter of the Cortical Surface in Persons with Schizophrenia
- (2013) Tiziano Colibazzi et al. PLoS One
- White matter deficits in first episode schizophrenia: An activation likelihood estimation meta-analysis
- (2013) Li Yao et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Future perspectives on the treatment of cognitive deficits and negative symptoms in schizophrenia
- (2013) Donald C. Goff World Psychiatry
- Deficits in Transcriptional Regulators of Cortical Parvalbumin Neurons in Schizophrenia
- (2012) David W. Volk et al. AMERICAN JOURNAL OF PSYCHIATRY
- Elevated Prefrontal Cortex γ-Aminobutyric Acid and Glutamate-Glutamine Levels in Schizophrenia Measured In Vivo With Proton Magnetic Resonance Spectroscopy
- (2012) Xiangling Mao ARCHIVES OF GENERAL PSYCHIATRY
- The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment
- (2012) Oliver D. Howes et al. ARCHIVES OF GENERAL PSYCHIATRY
- Meta-Analysis of Lymphocytes in Schizophrenia: Clinical Status and Antipsychotic Effects
- (2012) Brian J. Miller et al. BIOLOGICAL PSYCHIATRY
- Early-Life Insults Impair Parvalbumin Interneurons via Oxidative Stress: Reversal by N-Acetylcysteine
- (2012) Jan-Harry Cabungcal et al. BIOLOGICAL PSYCHIATRY
- Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine
- (2012) Marisa Möller et al. BRAIN BEHAVIOR AND IMMUNITY
- Nitric Oxide and Schizophrenia: Present Knowledge and Emerging Concepts of Therapy
- (2012) Hans-Gert Bernstein et al. CNS & Neurological Disorders-Drug Targets
- Minocycline
- (2012) Olivia M. Dean et al. CNS DRUGS
- Cortical circuit dysfunction and cognitive deficits in schizophrenia - implications for preemptive interventions
- (2012) David A. Lewis EUROPEAN JOURNAL OF NEUROSCIENCE
- The relationship between oxidative stress and post-translational modification of the dopamine transporter in bipolar disorder
- (2012) Helena Kyunghee Kim et al. Expert Review of Neurotherapeutics
- Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset
- (2012) Philippe A. Melas et al. FASEB JOURNAL
- Myelination and oxidative stress alterations in the cerebellum of the G72/G30 transgenic schizophrenia mouse model
- (2012) Michaela D. Filiou et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity
- (2012) Mariana Pedrini et al. JOURNAL OF PSYCHIATRIC RESEARCH
- The metabolic syndrome in schizophrenia: is inflammation a contributing cause?
- (2012) Brian E Leonard et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment
- (2012) Imran B Chaudhry et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance and therapeutic implications
- (2012) S Moylan et al. MOLECULAR PSYCHIATRY
- Role of glutamic acid decarboxylase 67 in regulating cortical parvalbumin and GABA membrane transporter 1 expression: Implications for schizophrenia
- (2012) Allison A. Curley et al. NEUROBIOLOGY OF DISEASE
- N-Acetylcysteine Reverses Mitochondrial Dysfunctions and Behavioral Abnormalities in 3-Nitropropionic Acid-Induced Huntington’s Disease
- (2012) Rajat Sandhir et al. Neurodegenerative Diseases
- Social isolation rearing in rats alters plasma tryptophan metabolism and is reversed by sub-chronic clozapine treatment
- (2012) Marisa Möller et al. NEUROPHARMACOLOGY
- Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice
- (2012) Francesco Matrisciano et al. NEUROPHARMACOLOGY
- Dendritic spine pathology in schizophrenia
- (2012) J.R. Glausier et al. NEUROSCIENCE
- Glutathione Precursor N-Acetyl-Cysteine Modulates EEG Synchronization in Schizophrenia Patients: A Double-Blind, Randomized, Placebo-Controlled Trial
- (2012) Cristian Carmeli et al. PLoS One
- Regional Brain Atrophy and Functional Disconnection in Broca’s Area in Individuals at Ultra-High Risk for Psychosis and Schizophrenia
- (2012) Wi Hoon Jung et al. PLoS One
- Relationship between inflammation and metabolic syndrome following treatment with paliperidone for schizophrenia
- (2012) Kyoung-Sae Na et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia
- (2012) George Anderson et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Prenatal inflammation and neurodevelopment in schizophrenia: A review of human studies
- (2012) Brian J. Miller et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Putative neuroprotective agents in neuropsychiatric disorders
- (2012) Seetal Dodd et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Schizophrenia: Linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression
- (2012) George Anderson et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Clinical and biochemical validation of two endophenotypes of schizophrenia defined by levels of polyunsaturated fatty acids in red blood cells
- (2012) H. Bentsen et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Spatial Characteristics of White Matter Abnormalities in Schizophrenia
- (2012) T. White et al. SCHIZOPHRENIA BULLETIN
- Inhibitory Interneurons, Oxidative Stress, and Schizophrenia
- (2012) E. M. Sullivan et al. SCHIZOPHRENIA BULLETIN
- The Myth of Schizophrenia as a Progressive Brain Disease
- (2012) Robert B. Zipursky et al. SCHIZOPHRENIA BULLETIN
- Localized gray matter volume reductions in the pars triangularis of the inferior frontal gyrus in individuals at clinical high-risk for psychosis and first episode for schizophrenia
- (2012) Norichika Iwashiro et al. SCHIZOPHRENIA RESEARCH
- Longitudinal progression of frontal and temporal lobe changes in schizophrenia
- (2012) Derin J. Cobia et al. SCHIZOPHRENIA RESEARCH
- NADPH oxidase elevations in pyramidal neurons drive psychosocial stress-induced neuropathology
- (2012) S Schiavone et al. Translational Psychiatry
- Conserved Interneuron-Specific ErbB4 Expression in Frontal Cortex of Rodents, Monkeys, and Humans: Implications for Schizophrenia
- (2011) Jörg Neddens et al. BIOLOGICAL PSYCHIATRY
- Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
- (2011) Brian J. Miller et al. BIOLOGICAL PSYCHIATRY
- Are There Progressive Brain Changes in Schizophrenia? A Meta-Analysis of Structural Magnetic Resonance Imaging Studies
- (2011) Bayanne Olabi et al. BIOLOGICAL PSYCHIATRY
- Progressive Brain Change in Schizophrenia: A Prospective Longitudinal Study of First-Episode Schizophrenia
- (2011) Nancy C. Andreasen et al. BIOLOGICAL PSYCHIATRY
- Imaging Changes in Glutamate Transmission In Vivo with the Metabotropic Glutamate Receptor 5 Tracer [11C] ABP688 and N-Acetylcysteine Challenge
- (2011) Nobumi Miyake et al. BIOLOGICAL PSYCHIATRY
- Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients
- (2011) A.M. Myint et al. BRAIN BEHAVIOR AND IMMUNITY
- Perisomatic inhibition and cortical circuit dysfunction in schizophrenia
- (2011) David A Lewis et al. CURRENT OPINION IN NEUROBIOLOGY
- Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder
- (2011) Emma L. Dempster et al. HUMAN MOLECULAR GENETICS
- An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forces
- (2011) Roosmarijn C. Drexhage et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Clozapine Protects Dopaminergic Neurons from Inflammation-Induced Damage by Inhibiting Microglial Overactivation
- (2011) Xiaoming Hu et al. Journal of Neuroimmune Pharmacology
- Prenatal immune challenge compromises development of upper-layer but not deeper-layer neurons of the mouse cerebral cortex
- (2011) Hitomi Soumiya et al. JOURNAL OF NEUROSCIENCE RESEARCH
- The course of brain abnormalities in schizophrenia: can we slow the progression?
- (2011) NE Van Haren et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Behavioral changes and mitochondrial dysfunction in a rat model of schizophrenia induced by ketamine
- (2011) Larissa de Oliveira et al. METABOLIC BRAIN DISEASE
- Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals
- (2011) G P Amminger et al. MOLECULAR PSYCHIATRY
- Genome-wide association study identifies five new schizophrenia loci
- (2011) NATURE GENETICS
- Epigenetic and post-transcriptional dysregulation of gene expression in schizophrenia and related disease
- (2011) David P. Gavin et al. NEUROBIOLOGY OF DISEASE
- To poly(I:C) or not to poly(I:C): Advancing preclinical schizophrenia research through the use of prenatal immune activation models
- (2011) Urs Meyer et al. NEUROPHARMACOLOGY
- Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia
- (2011) Susan B. Powell et al. NEUROPHARMACOLOGY
- N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and d-amphetamine-treated rats: Relevance to schizophrenia and bipolar disorder
- (2011) Olivia M. Dean et al. NEUROSCIENCE LETTERS
- The cystine–glutamate transporter enhancer N-acetyl-l-cysteine attenuates cocaine-induced changes in striatal dopamine but not self-administration in squirrel monkeys
- (2011) Rayna M. Bauzo et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder
- (2011) Hamid Mostafavi Abdolmaleky et al. SCHIZOPHRENIA RESEARCH
- Adjunct minocycline to clozapine treated patients with persistent schizophrenia symptoms
- (2011) Deanna L. Kelly et al. SCHIZOPHRENIA RESEARCH
- Asymmetry of lexico-semantic processing in schizophrenia changes with disease progression
- (2011) M. Lam et al. SCHIZOPHRENIA RESEARCH
- Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia
- (2011) Daniel C. Javitt et al. SCHIZOPHRENIA RESEARCH
- Evidence of aberrant DNA damage response signalling but normal rates of DNA repair in dividing lymphoblasts from patients with schizophrenia
- (2011) Vibeke Sørensen Catts et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Neuroprotective Effects of Cognitive Enhancement Therapy Against Gray Matter Loss in Early Schizophrenia
- (2010) Shaun M. Eack et al. ARCHIVES OF GENERAL PSYCHIATRY
- Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders
- (2010) G. Paul Amminger et al. ARCHIVES OF GENERAL PSYCHIATRY
- Effects of prenatal infection on brain development and behavior: A review of findings from animal models
- (2010) Patricia Boksa BRAIN BEHAVIOR AND IMMUNITY
- The neurobiology of schizophrenia: new leads and avenues for treatment
- (2010) Nicholas J Bray et al. CURRENT OPINION IN NEUROBIOLOGY
- Isolation rearing-induced deficits in sensorimotor gating and social interaction in rats are related to cortico-striatal oxidative stress, and reversed by sub-chronic clozapine administration
- (2010) Marisa Möller et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Activity-dependent neuroprotective protein (ADNP) expression level is correlated with the expression of the sister protein ADNP2: Deregulation in schizophrenia
- (2010) Efrat Dresner et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia
- (2010) Hayley B. Clay et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE
- Qualitative Methods in Early-Phase Drug Trials
- (2010) Michael Berk et al. JOURNAL OF CLINICAL PSYCHIATRY
- Adjuvant Aspirin Therapy Reduces Symptoms of Schizophrenia Spectrum Disorders
- (2010) Wijnand Laan et al. JOURNAL OF CLINICAL PSYCHIATRY
- Biochemical and Functional Interaction of Disrupted-in-Schizophrenia 1 and Amyloid Precursor Protein Regulates Neuronal Migration during Mammalian Cortical Development
- (2010) T. L. Young-Pearse et al. JOURNAL OF NEUROSCIENCE
- The NADPH Oxidase NOX2 Controls Glutamate Release: A Novel Mechanism Involved in Psychosis-Like Ketamine Responses
- (2010) S. Sorce et al. JOURNAL OF NEUROSCIENCE
- Epigenetic GABAergic targets in schizophrenia and bipolar disorder
- (2010) A. Guidotti et al. NEUROPHARMACOLOGY
- Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors
- (2010) M. Berk et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Oxidative stress in schizophrenia: An integrated approach
- (2010) Byron K.Y. Bitanihirwe et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment
- (2010) Norbert Müller et al. SCHIZOPHRENIA RESEARCH
- Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8
- (2010) Lauren M. Ellman et al. SCHIZOPHRENIA RESEARCH
- Gamma Oscillation Deficits and the Onset and Early Progression of Schizophrenia
- (2010) Tsung-Ung W. Woo et al. HARVARD REVIEW OF PSYCHIATRY
- Involvement of NOX2 in the Development of Behavioral and Pathologic Alterations in Isolated Rats
- (2009) Stefania Schiavone et al. BIOLOGICAL PSYCHIATRY
- Oxidative stress and neopterin abnormalities in schizophrenia: A longitudinal study
- (2009) Seetharamaiah Chittiprol et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes
- (2009) Juan E Belforte et al. NATURE NEUROSCIENCE
- GABAA receptors and their associated proteins: Implications in the etiology and treatment of schizophrenia and related disorders
- (2009) Erik I. Charych et al. NEUROPHARMACOLOGY
- Epigenetic Profiling in Schizophrenia and Major Mental Disorders
- (2009) Kazuya Iwamoto et al. NEUROPSYCHOBIOLOGY
- The effects of sub-chronic clozapine and haloperidol administration on isolation rearing induced changes in frontal cortical N-methyl-d-aspartate and D1 receptor binding in rats
- (2009) C. Toua et al. NEUROSCIENCE
- Brain Anatomical Abnormalities in High-Risk Individuals, First-Episode, and Chronic Schizophrenia: An Activation Likelihood Estimation Meta-analysis of Illness Progression
- (2009) R. C. K. Chan et al. SCHIZOPHRENIA BULLETIN
- The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
- (2009) O. D. Howes et al. SCHIZOPHRENIA BULLETIN
- Psychotropic drugs up-regulate the expression of cholesterol transport proteins including ApoE in cultured human CNS- and liver cells
- (2009) Audun O Vik-Mo et al. BMC Pharmacology & Toxicology
- A comparative study of oxidative stress and interrelationship of important antioxidants in haloperidol and olanzapine treated patients suffering from schizophrenia
- (2009) OmPrakash Singh et al. Indian Journal of Psychiatry
- The Anatomy of First-Episode and Chronic Schizophrenia: An Anatomical Likelihood Estimation Meta-Analysis
- (2008) Ian Ellison-Wright et al. AMERICAN JOURNAL OF PSYCHIATRY
- Longitudinal Progression of Movement Abnormalities in Relation to Psychotic Symptoms in Adolescents at High Risk of Schizophrenia
- (2008) Vijay A. Mittal et al. ARCHIVES OF GENERAL PSYCHIATRY
- N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial
- (2008) Michael Berk et al. BIOLOGICAL PSYCHIATRY
- Elevated Cerebrospinal Fluid Lactate Concentrations in Patients with Bipolar Disorder and Schizophrenia: Implications for the Mitochondrial Dysfunction Hypothesis
- (2008) William T. Regenold et al. BIOLOGICAL PSYCHIATRY
- Disease-specific alterations in glutamatergic neurotransmission on inhibitory interneurons in the prefrontal cortex in schizophrenia
- (2008) Tsung-Ung W. Woo et al. BRAIN RESEARCH
- Dopamine and serotonin levels following prenatal viral infection in mouse—Implications for psychiatric disorders such as schizophrenia and autism
- (2008) Christine Winter et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Inflammation and the glutamate system in schizophrenia: implications for therapeutic targets and drug development
- (2008) Norbert Müller EXPERT OPINION ON THERAPEUTIC TARGETS
- Mitochondrial diseases mimicking neurotransmitter defects
- (2008) Angels Garcia-Cazorla et al. MITOCHONDRION
- Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk
- (2008) K K Nicodemus et al. MOLECULAR PSYCHIATRY
- Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice
- (2008) Haruhiko Sugino et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Coagulation and inflammation markers during atypical or typical antipsychotic treatment in schizophrenia patients and drug-free first-degree relatives
- (2008) Edgardo Carrizo et al. SCHIZOPHRENIA RESEARCH
- Aripiprazole and its human metabolite OPC14857 reduce, through a presynaptic mechanism, glutamate release in rat prefrontal cortex: Possible relevance to neuroprotective interventions in schizophrenia
- (2008) Tsung-Tsair Yang et al. SYNAPSE
- Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia
- (2008) John E. Lisman et al. TRENDS IN NEUROSCIENCES
- Isoprostenes as indicators of oxidative stress in schizophrenia
- (2008) Anna Dietrich-Muszalska et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Winter/summer seasonal changes in malondialdehyde formation as a source of variance in oxidative stress schizophrenia research
- (2008) Armando L. Morera et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Functional Polymorphisms in PRODH Are Associated with Risk and Protection for Schizophrenia and Fronto-Striatal Structure and Function
- (2008) Lucas Kempf et al. PLoS Genetics
- Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review
- (2007) Stéphane Potvin et al. BIOLOGICAL PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More